Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 82 articles:
HTML format
Text format



Single Articles


    November 2017
  1. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  2. SLOMSKI A
    Continuous Glucose Monitoring in Pregnant Women With Diabetes.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  3. KRISCHER JP, Schatz DA, Bundy B, Skyler JS, et al
    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1891-1902.
    PubMed     Text format     Abstract available


  4. LANE W, Bailey TS, Gerety G
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
    JAMA. 2017;318:1828-1829.
    PubMed     Text format    


  5. ZULEWSKI H, Keller U
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes.
    JAMA. 2017;318:1828.
    PubMed     Text format    


  6. SHAHRAZ S, Pittas AG, Saadati M, Thomas CP, et al
    Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014.
    JAMA. 2017;318:1825-1827.
    PubMed     Text format    


    October 2017
  7. SLOMSKI A
    Liraglutide May Reduce Diabetic Kidney Disease.
    JAMA. 2017;318:1532.
    PubMed     Text format    


  8. GAO P, Tang X, Hu Y
    Prediabetes Prevalence in China-Reply.
    JAMA. 2017;318:1612-1613.
    PubMed     Text format    


  9. FU N, Jiang Y, Sun W
    Prediabetes Prevalence in China.
    JAMA. 2017;318:1611-1612.
    PubMed     Text format    


  10. DAVIES M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, et al
    Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1460-1470.
    PubMed     Text format     Abstract available


  11. VOS RC, Rutten GEHM
    Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    JAMA. 2017;318:1489-1490.
    PubMed     Text format     Abstract available


  12. KARGES B, Schwandt A, Heidtmann B, Kordonouri O, et al
    Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    JAMA. 2017;318:1358-1366.
    PubMed     Text format     Abstract available


  13. HART T, Milner R, Cifu A
    Management of a Diabetic Foot.
    JAMA. 2017;318:1387-1388.
    PubMed     Text format    


    August 2017
  14. JOHANSEN MY, MacDonald CS, Hansen KB, Karstoft K, et al
    Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:637-646.
    PubMed     Text format     Abstract available


  15. KUEHN BM
    Pilot Programs Seek to Integrate Genomic Data Into Practice.
    JAMA. 2017;318:410-412.
    PubMed     Text format    


    July 2017
  16. ZHENG Y, Manson JE, Yuan C, Liang MH, et al
    Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life.
    JAMA. 2017;318:255-269.
    PubMed     Text format     Abstract available


  17. LIPSKA KJ, Krumholz HM
    Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies-Reply.
    JAMA. 2017;318:200-201.
    PubMed     Text format    


  18. VENKER BT
    Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies.
    JAMA. 2017;318:200.
    PubMed     Text format    


  19. RUBIN R
    Starch-Based "Super Food" May Protect Against Variety of Diseases.
    JAMA. 2017;318:112-114.
    PubMed     Text format    


  20. WYSHAM C, Bhargava A, Chaykin L, de la Rosa R, et al
    Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
    JAMA. 2017;318:45-56.
    PubMed     Text format     Abstract available


  21. LANE W, Bailey TS, Gerety G, Gumprecht J, et al
    Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
    JAMA. 2017;318:33-44.
    PubMed     Text format     Abstract available


  22. SEAQUIST ER, Chow LS
    Hypoglycemia in Diabetes: Does Insulin Type Matter?
    JAMA. 2017;318:31-32.
    PubMed     Text format    


    June 2017
  23. ABBASI J
    Can a Diet That Mimics Fasting Turn Back the Clock?
    JAMA. 2017 Jun 28. doi: 10.1001/jama.2017.6648.
    PubMed     Text format    


  24. WANG L, Gao P, Zhang M, Huang Z, et al
    Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.
    JAMA. 2017;317:2515-2523.
    PubMed     Text format     Abstract available


  25. DABELEA D, D'Agostino R Jr, Mayer-Davis EJ
    Complications of Diabetes Diagnosed in Children and Adolescents-Reply.
    JAMA. 2017;317:2553-2554.
    PubMed     Text format    


  26. IBANEZ-BRURON MC, Solebo AL, Rahi JS
    Complications of Diabetes Diagnosed in Children and Adolescents.
    JAMA. 2017;317:2553.
    PubMed     Text format    


  27. PENG S, Li C, Sun X
    Complications of Diabetes Diagnosed in Children and Adolescents.
    JAMA. 2017;317:2552-2553.
    PubMed     Text format    


  28. LIPSKA KJ, Hirsch IB, Riddle MC
    Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.
    JAMA. 2017 Jun 12. doi: 10.1001/jama.2017.6939.
    PubMed     Text format    


  29. CHEW EY
    Dietary Intake of Omega-3 Fatty Acids From Fish and Risk of Diabetic Retinopathy.
    JAMA. 2017;317:2226-2227.
    PubMed     Text format    


  30. CAUGHEY AB
    Gestational Weight Gain and Outcomes for Mothers and Infants.
    JAMA. 2017;317:2175-2176.
    PubMed     Text format    


  31. GOLDSTEIN RF, Abell SK, Ranasinha S, Misso M, et al
    Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis.
    JAMA. 2017;317:2207-2225.
    PubMed     Text format     Abstract available


    May 2017
  32. ABBASI J
    Increase in Diabetes Cases Among Young People.
    JAMA. 2017;317:2053.
    PubMed     Text format    


    April 2017
  33. SLOMSKI A
    Bariatric Surgery Has Durable Effects in Controlling Diabetes.
    JAMA. 2017;317:1615.
    PubMed     Text format    


  34. BRAGG F, Li L, Chen Z
    Urban-Rural Differences in Diabetes-Associated Mortality in China-Reply.
    JAMA. 2017;317:1689.
    PubMed     Text format    


  35. WANG H, Lai Y
    Urban-Rural Differences in Diabetes in China.
    JAMA. 2017;317:1688-1689.
    PubMed     Text format    


  36. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Text format     Abstract available


    March 2017

  37. Metformin for Prediabetes.
    JAMA. 2017;317:1171.
    PubMed     Text format    


  38. MICHA R, Penalvo JL, Cudhea F, Imamura F, et al
    Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States.
    JAMA. 2017;317:912-924.
    PubMed     Text format     Abstract available


  39. REUSCH JE, Manson JE
    Management of Type 2 Diabetes in 2017: Getting to Goal.
    JAMA. 2017 Mar 1. doi: 10.1001/jama.2017.0241.
    PubMed     Text format    


    February 2017
  40. DABELEA D, Stafford JM, Mayer-Davis EJ, D'Agostino R Jr, et al
    Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood.
    JAMA. 2017;317:825-835.
    PubMed     Text format     Abstract available


  41. EMDIN CA, Khera AV, Natarajan P, Klarin D, et al
    Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
    JAMA. 2017;317:626-634.
    PubMed     Text format     Abstract available


  42. ABBASI J
    Unveiling the "Magic" of Diabetes Remission After Weight-Loss Surgery.
    JAMA. 2017;317:571-574.
    PubMed     Text format    


  43. BRITO JP, Montori VM, Davis AM
    Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.
    JAMA. 2017;317:635-636.
    PubMed     Text format    


  44. XIANG AH
    Association of Maternal Diabetes With Autism in Offspring.
    JAMA. 2017;317:537-538.
    PubMed     Text format    


  45. HAMPTON T
    Drug Under Study for Diabetes a Potential Parkinson Therapy.
    JAMA. 2017;317:465.
    PubMed     Text format    


  46. LACY ME, Wellenius GA, Sumner AE, Correa A, et al
    Association of Sickle Cell Trait With Hemoglobin A1c in African Americans.
    JAMA. 2017;317:507-515.
    PubMed     Text format     Abstract available


    January 2017
  47. LIPSKA KJ, Krumholz HM
    Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
    JAMA. 2017 Jan 26. doi: 10.1001/jama.2017.0029.
    PubMed     Text format    


  48. LIND M, Polonsky W, Hirsch IB, Heise T, et al
    Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    JAMA. 2017;317:379-387.
    PubMed     Text format     Abstract available


  49. BECK RW, Riddlesworth T, Ruedy K, Ahmann A, et al
    Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    JAMA. 2017;317:371-378.
    PubMed     Text format     Abstract available


  50. DAVIDSON MB
    Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
    JAMA. 2017;317:363-364.
    PubMed     Text format    


  51. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available


  52. VOELKER R
    Diabetes Drug Gains New Indication.
    JAMA. 2017;317:247.
    PubMed     Text format    


  53. CHAN M
    China's Burgeoning Epidemic of Diabetes-Associated Mortality.
    JAMA. 2017;317:264-266.
    PubMed     Text format    


    December 2016
  54. KOMAROFF AL
    The Microbiome and Risk for Obesity and Diabetes.
    JAMA. 2016 Dec 22. doi: 10.1001/jama.2016.20099.
    PubMed     Text format    


  55. ABBASI J
    NIH Charts a Path for Nutrition Science.
    JAMA. 2016 Dec 14. doi: 10.1001/jama.2016.18217.
    PubMed     Text format    


  56. MARGULIES KB, McNulty SE, Cappola TP
    Lack of Benefit for Liraglutide in Heart Failure-Reply.
    JAMA. 2016;316:2429-2430.
    PubMed     Text format    


  57. CARBONE S, Arena R, Abbate A
    Lack of Benefit for Liraglutide in Heart Failure.
    JAMA. 2016;316:2429.
    PubMed     Text format    


    November 2016
  58. WONG TY, Bressler NM
    Artificial Intelligence With Deep Learning Technology Looks Into Diabetic Retinopathy Screening.
    JAMA. 2016 Nov 29. doi: 10.1001/jama.2016.17563.
    PubMed     Text format    


  59. GULSHAN V, Peng L, Coram M, Stumpe MC, et al
    Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs.
    JAMA. 2016 Nov 29. doi: 10.1001/jama.2016.17216.
    PubMed     Text format     Abstract available


    October 2016
  60. SLOMSKI A
    Eating Oily Fish May Protect Against Diabetic Retinopathy.
    JAMA. 2016;316:1637.
    PubMed     Text format    


  61. SCHILLINGER D, Jacobson MF
    Science and Public Health on Trial: Warning Notices on Advertisements for Sugary Drinks.
    JAMA. 2016;316:1545-1546.
    PubMed     Text format    


  62. LOTTA LA, Sharp SJ, Burgess S, Perry JR, et al
    Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
    JAMA. 2016;316:1383-1391.
    PubMed     Text format     Abstract available


    September 2016
  63. SLOMSKI A
    Telemonitoring Helps Keep Diabetes Under Control.
    JAMA. 2016;316:1250.
    PubMed     Text format    


  64. VOELKER R
    Injectable Diabetes Drug Approved.
    JAMA. 2016;316:1142.
    PubMed     Text format    


  65. BERGENSTAL RM, Garg S, Weinzimer SA, Buckingham BA, et al
    Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
    JAMA. 2016 Sep 15. doi: 10.1001/jama.2016.11708.
    PubMed     Text format    


    August 2016
  66. HALL M, Dondo TB, Yan AT, Goodman SG, et al
    Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013.
    JAMA. 2016 Aug 30. doi: 10.1001/jama.2016.10766.
    PubMed     Text format     Abstract available


  67. BEYERLEIN A, Donnachie E, Ziegler AG
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes--Reply.
    JAMA. 2016;316:883.
    PubMed     Text format    


  68. UZOIGWE OF
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes.
    JAMA. 2016;316:882-3.
    PubMed     Text format    


  69. RAHMOUNE H, Boutrid N, Bioud B
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes.
    JAMA. 2016;316:882.
    PubMed     Text format    


  70. REISS-BRENNAN B, Brunisholz KD, Dredge C, Briot P, et al
    Association of Integrated Team-Based Care With Health Care Quality, Utilization, and Cost.
    JAMA. 2016;316:826-34.
    PubMed     Text format     Abstract available


  71. AFKARIAN M, Zelnick LR, Hall YN, Heagerty PJ, et al
    Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
    JAMA. 2016;316:602-10.
    PubMed     Text format     Abstract available


  72. HUA X, Herman WH, Clarke P
    Cost of Antihyperglycemic Medications in the United States--Reply.
    JAMA. 2016;316:665-6.
    PubMed     Text format    


  73. ALATORRE C, Schultz EH, Nelson DR
    Cost of Antihyperglycemic Medications in the United States.
    JAMA. 2016;316:665.
    PubMed     Text format    


  74. CHATTERJEE S
    Laboratory Testing in the Setting of Diabetic Scleredema--Reply.
    JAMA. 2016;316:543.
    PubMed     Text format    


  75. ALTER D
    Laboratory Testing in the Setting of Diabetic Scleredema.
    JAMA. 2016;316:542.
    PubMed     Text format    


  76. MARGULIES KB, Hernandez AF, Redfield MM, Givertz MM, et al
    Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
    JAMA. 2016;316:500-8.
    PubMed     Text format     Abstract available


    July 2016
  77. LIPSKA KJ
    JAMA PATIENT PAGE. Diabetes in Older People.
    JAMA. 2016;316:362.
    PubMed     Text format    


  78. MENKE A, Casagrande S, Cowie CC
    Prevalence of Diabetes in Adolescents Aged 12 to 19 Years in the United States, 2005-2014.
    JAMA. 2016;316:344-5.
    PubMed     Text format    


  79. PALMER SC, Mavridis D, Nicolucci A, Johnson DW, et al
    Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.
    JAMA. 2016;316:313-24.
    PubMed     Text format     Abstract available


    May 2016
  80. CREATORE MI, Glazier RH, Moineddin R, Fazli GS, et al
    Association of Neighborhood Walkability With Change in Overweight, Obesity, and Diabetes.
    JAMA. 2016;315:2211-20.
    PubMed     Text format     Abstract available


  81. RUNDLE AG, Heymsfield SB
    Can Walkable Urban Design Play a Role in Reducing the Incidence of Obesity-Related Conditions?
    JAMA. 2016;315:2175-7.
    PubMed     Text format    


    March 2016
  82. YEH RW, Secemsky EA, Kereiakes DJ, Normand ST, et al
    Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
    JAMA. 2016 Mar 29. doi: 10.1001/jama.2016.3775.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: